Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunization With a Novel Chimeric Peptide Representing B and T Cell Epitopes From Her2 Extracellular Domain (Her2 Ecd) for Breast Cancer Publisher Pubmed



Mahdavi M1 ; Keyhanfar M2 ; Jafarian A1 ; Mohabatkar H2 ; Rabbani M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Biotechnology, University of Isfahan, Isfahan, 81746-73441, Iran

Source: Tumor Biology Published:2014


Abstract

Because of direct stimulating immune system against disease, vaccination or active immunotherapy is preferable compared to passive immunotherapy. For this purpose, a newly designed chimeric peptide containing epitopes for both B and T cells from HER2 ECD subdomain III was proposed. To evaluate the effects of the active immunization, a discontinuous B cell epitope peptide was selected based on average antigenicity by bioinformatics analysis. The selected peptide was collinearly synthesized as a chimera with a T helper epitope from the protein sequence of measles virus fusion (208-302) using the GPSL linker. Three mice were immunized with the chimeric peptide. Reactive antibodies with HER2 protein in ELISA and immunofluorescence assays with no cross-reactivity were generated. The 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay indicated that the anti-peptide sera had inhibitory effects on proliferation of SK-BR-3 cells. Hence, the newly designed, discontinuous chimeric peptide representing B and T cell epitopes from subdomain III of HER2-ECD can form the basis for future vaccines design, where these data can be applied for monoclonal antibody production targeting the distinct epitope of HER2 receptor compared to the two broadly used anti-HER2 monoclonal antibodies, Herceptin and pertuzumab. © 2014, International Society of Oncology and BioMarkers (ISOBM).
Related Docs
View other Related Docs
1. In Silico Design of Discontinuous Peptides Representative of B and T-Cell Epitopes From Her2-Ecd As Potential Novel Cancer Peptide Vaccines, Asian Pacific Journal of Cancer Prevention (2013)
2. Linear and Conformational B Cell Epitope Prediction of the Her 2 Ecd-Subdomain Iii by in Silico Methods, Asian Pacific Journal of Cancer Prevention (2012)
3. Production and Characterization of New Anti-Her2 Monoclonal Antibodies, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2015)
4. In Silico Designing Breast Cancer Peptide Vaccine for Binding to Mhc Class I and Ii: A Molecular Docking Study, Computational Biology and Chemistry (2016)
5. In Silico Analysis of Synaptonemal Complex Protein 1 (Sycp1) and Acrosin Binding Protein (Acrbp) Antigens to Design Novel Multiepitope Peptide Cancer Vaccine Against Breast Cancer, International Journal of Peptide Research and Therapeutics (2019)
6. Identification of B and T Cell Epitope Based Peptide Vaccine From Igf-1 Receptor in Breast Cancer, Journal of Molecular Graphics and Modelling (2017)
7. Efficacy of Co-Immunization With the Dna and Peptide Vaccines Containing Sycp1 and Acrbp Epitopes in a Murine Triple-Negative Breast Cancer Model, Human Vaccines and Immunotherapeutics (2021)
8. Novel Sars-Cov2 Poly Epitope Phage-Based Candidate Vaccine and Its Immunogenicity, Research in Pharmaceutical Sciences (2024)
Experts (# of related papers)
View all Related Experts
Abbas Jafarian (3)
Seyed Hossein Hejazi (2)
Other Related Docs
9. Bioinformatics Design of a Peptide Vaccine Containing Sarcoma Antigen Ny-Sar-35 Epitopes Against Breast Cancer and Evaluation of Its Immunological Function in Balb/C Mouse Model, PLoS ONE (2024)
10. Immunoprotective Effect of an in Silico Designed Multiepitope Cancer Vaccine With Boris Cancer-Testis Antigen Target in a Murine Mammary Carcinoma Model, Scientific Reports (2021)
11. Development of Polyepitopic Immunogenic Contrast Against Hepatitis C Virus 1A-6A Genotype by in Silico Approach, Biomedical and Biotechnology Research Journal (2020)
12. Exploring the Out of Sight Antigens of Sars-Cov-2 to Design a Candidate Multi-Epitope Vaccine by Utilizing Immunoinformatics Approaches, Vaccine (2020)
13. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
14. Exploring the Cancer-Testis Antigen Boris to Design a Novel Multi-Epitope Vaccine Against Breast Cancer Based on Immunoinformatics Approaches, Journal of Biomolecular Structure and Dynamics (2022)
15. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
16. Immunoinformatic Approach to the Design of a Novel Multi-Epitope Vaccine Against Leishmania Major Fused to Human Igg-Fc, Research in Pharmaceutical Sciences (2024)
17. Production, Purification, and in Vivo Evaluation of a Novel Multiepitope Peptide Vaccine Consisted of Immunodominant Epitopes of Sycp1 and Acrbp Antigens As a Prophylactic Melanoma Vaccine, International Immunopharmacology (2019)
18. Development of a Chimeric Vaccine Candidate Based on Toxoplasma Gondii Major Surface Antigen 1 and Apicoplast Proteins Using Comprehensive Immunoinformatics Approaches, European Journal of Pharmaceutical Sciences (2021)
19. In Silico Analysis of Transmembrane Protein 31 (Tmem31)Antigen to Design Novel Multiepitope Peptide and Dna Cancer Vaccines Against Melanoma, Molecular Immunology (2019)
20. Immune and Bioinformatics Identification of T Cell and B Cell Epitopes in the Protein Structure of Sars-Cov-2: A Systematic Review, International Immunopharmacology (2020)